Nanovaccine Design Boosts Immune Attack on HPV Tumors
Key Highlights Reconfiguring peptide orientation significantly strengthened the CD8+ T cell response. Surface-displayed antigen (N-terminus attachment) showed superior tumor control.
Read MoreKey Highlights Reconfiguring peptide orientation significantly strengthened the CD8+ T cell response. Surface-displayed antigen (N-terminus attachment) showed superior tumor control.
Read MoreA vaccine activated and encouraged subtype of CD8 T cells, which are often thought to stimulate immune system responses, may
Read More